Holdings

Fairmount Funds Management LLC

As of Sep 30, 2026, Fairmount Funds Management LLC reported 10 positions worth US$1.12B. Largest: Oruka Therapeutics, Inc., Dianthus Therapeutics, Inc. and Cogent Biosciences, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Oruka Therapeutics, Inc.3.71MUS$309Mno changeSep 30, 2026
Dianthus Therapeutics, Inc.2.54MUS$223Mno changeSep 30, 2026
Cogent Biosciences, Inc.5.5MUS$176Mno changeSep 30, 2026
Viridian Therapeutics, Inc.5.09MUS$105Mno changeSep 30, 2026
Enliven Therapeutics, Inc.1.86MUS$85.1Mno changeSep 30, 2026
Jade Biosciences, Inc.4.55MUS$64Mno changeSep 30, 2026
Zenas BioPharma, Inc.2.37MUS$64M+12,333Sep 30, 2026
Crescent Biopharma, Inc.3.6MUS$52.5M+853KSep 30, 2026
Sensei Biotherapeutics, Inc.722KUS$21.5Mno changeSep 30, 2026
Inhibikase Therapeutics, Inc.8.63MUS$17.7Mno changeSep 30, 2026